General News Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…John BuckleyNovember 22, 2021
General News Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…John BuckleySeptember 27, 2021
Psychiatry News Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…John BuckleyFebruary 17, 2021
Psychiatry News Saladax Hires 8 to Address Demand for Schizophrenia Medication Test Saladax Biomedical, Inc., Ben Franklin TechVentures, Bethlehem, has expanded its staff with eight new employees in…John BuckleyOctober 13, 2020
Psychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…John BuckleyJuly 8, 2020
Psychiatry News HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…John BuckleyJune 27, 2020
Oncology News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…John BuckleyMay 4, 2020
Psychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…John BuckleyMay 1, 2020
Psychiatry News Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…John BuckleyOctober 24, 2019
Psychiatry News Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…John BuckleySeptember 5, 2019